{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-040903","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.957034+00:00","generated_at":"2026-06-02T09:55:32.724365+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tenon Medical receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days","bullets":["Nasdaq letter dated May 7, 2024, citing 30 consecutive business days below $1.00 minimum bid price from Mar 25 to May 6.","Initial 180-day compliance period runs until November 4, 2024, to regain compliance with Bid Price Rule.","If not cured, company may qualify for a second 180-day period if it meets other listing standards and notifies intent to cure.","Company is evaluating options; no immediate impact on listing, but no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-040903","json":"https://secwatch.observer/filing/0001213900-24-040903.json","markdown":"https://secwatch.observer/filing/0001213900-24-040903.md","text":"https://secwatch.observer/filing/0001213900-24-040903.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/0001213900-24-040903-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/ea0205567-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T09:55:32.724365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d0895e48a15f1dc0277e9fdbebaac756e0dd88c","claim":"Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"ule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/0001213900-24-040903-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}